Verona Pharma PLC (NAS:VRNA)
$ 30.01 -0.16 (-0.53%) Market Cap: 2.44 Bil Enterprise Value: 2.17 Bil PE Ratio: 0 PB Ratio: 14.42 GF Score: 29/100

Verona Pharma PLC Annual Shareholders Meeting Transcript

Apr 27, 2021 / 12:00PM GMT
Release Date Price: $7.48 (-1.45%)
Operator

Hello and welcome to the Verona Pharmaceuticals Annual General Meeting 2021 (Operator Instructions)

Please note, today's event is being recorded. I'd now like to turn the conference over to Dr. David Ebsworth. Dr. Ebsworth, please go ahead.

David Ebsworth

Thank you very much. Good day, ladies and gentlemen. It is my pleasure as a Chairman to welcome you to the Verona Pharma plc Annual General Meeting. I'm joined today by telephone by our nonexecutive Directors, our Chief Executive Officer, Dr. David Zaccardelli; our Chief Financial Officer, Mark Hahn; our General Counsel, Claire Poll; our company Secretary, Ben Harper; and representatives from our auditors, PwC. (Operator Instructions)

At the end of the meeting, we will hold a Q&A session during which we will answer questions relevant to the business of the company and the meetings matters.

As noted in our AGM notice, each shareholder is limited to 2 questions. Questions should be succinct and only cover a single topic. If it is not possible to answer any of the questions submitted

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot